TY - JOUR AU - Nowbar, A. N. AU - Howard, J. P. AU - Finegold, J. A. AU - Asaria, P. AU - Francis, D. P. PY - 2014 DA - 2014// TI - 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations JO - Int J Cardiol VL - 174 UR - https://doi.org/10.1016/j.ijcard.2014.04.096 DO - 10.1016/j.ijcard.2014.04.096 ID - Nowbar2014 ER - TY - JOUR AU - Barquera, S. AU - Pedroza-Tobías, A. AU - Medina, C. AU - Hernandez-Barrera, L. AU - Bibbins-Domingo, K. AU - Lozano, R. PY - 2015 DA - 2015// TI - Global overview of the epidemiology of atherosclerotic cardiovascular disease JO - Arch Med Res VL - 46 UR - https://doi.org/10.1016/j.arcmed.2015.06.006 DO - 10.1016/j.arcmed.2015.06.006 ID - Barquera2015 ER - TY - JOUR AU - Chen, W. W. AU - Gao, R. L. AU - Liu, L. S. AU - Zhu, M. L. AU - Wang, W. AU - Wang, Y. J. PY - 2018 DA - 2018// TI - Represent Chinese cardiovascular disease report group. Essentials of cardiovascular disease report in China JO - Chin Circ J VL - 33 ID - Chen2018 ER - TY - JOUR AU - Yang, G. H. AU - Wang, Y. AU - Zeng, Y. X. AU - Gao, G. F. AU - Liang, X. F. AU - Zhou, M. G. PY - 2013 DA - 2013// TI - Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)61097-1 DO - 10.1016/S0140-6736(13)61097-1 ID - Yang2013 ER - TY - JOUR AU - Marzilli, M. AU - Merz, C. N. AU - Boden, W. E. AU - Bonow, R. O. AU - Capozza, P. G. AU - Chilian, W. M. PY - 2012 DA - 2012// TI - Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! JO - J Am Coll Cardiol VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.02.082 DO - 10.1016/j.jacc.2012.02.082 ID - Marzilli2012 ER - TY - JOUR AU - Fihn, S. D. AU - Gardin, J. M. AU - Abrams, J. AU - Berra, K. AU - Blankenship, J. C. AU - Dallas, A. P. PY - 2012 DA - 2012// TI - 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease JO - J Am Coll Cardiol VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.07.013 DO - 10.1016/j.jacc.2012.07.013 ID - Fihn2012 ER - TY - JOUR AU - Windecker, S. AU - Kolh, P. AU - Alfonso, F. AU - Collet, J. P. AU - Cremer, J. AU - Falk, V. PY - 2014 DA - 2014// TI - 2014 ESC/EACTS Guidelines on myocardial revascularization JO - Eur Heart J VL - 35 UR - https://doi.org/10.1093/eurheartj/ehu278 DO - 10.1093/eurheartj/ehu278 ID - Windecker2014 ER - TY - JOUR AU - Maron, D. J. AU - Ting, H. H. PY - 2013 DA - 2013// TI - In mildly symptomatic patients, should an invasive strategy with catheterization and revascularization be routinely undertaken? In mildly symptomatic patients, an invasive strategy with catheterization and revascularization should not be routinely undertaken JO - Circ Cardiovasc Interv VL - 6 UR - https://doi.org/10.1161/CIRCINTERVENTIONS.112.973438 DO - 10.1161/CIRCINTERVENTIONS.112.973438 ID - Maron2013 ER - TY - JOUR AU - Helgason, C. M. AU - Bolin, K. M. AU - Hoff, J. A. AU - Winkler, S. R. AU - Mangat, A. AU - Tortorice, K. L. PY - 1994 DA - 1994// TI - Development of aspirin resistance in persons with previous ischemic stroke JO - Stroke VL - 25 UR - https://doi.org/10.1161/01.STR.25.12.2331 DO - 10.1161/01.STR.25.12.2331 ID - Helgason1994 ER - TY - JOUR AU - Münzel, T. AU - Daiber, A. AU - Gori, T. PY - 2013 DA - 2013// TI - Nitrate therapy: new aspects concerning molecular action and tolerance JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.981407 DO - 10.1161/CIRCULATIONAHA.110.981407 ID - Münzel2013 ER - TY - JOUR AU - Xu, L. J. AU - Huang, G. Y. PY - 2009 DA - 2009// TI - The chemical components and pharmacological effects of Danshen JO - Zhong Xi Yi Jie He Yan Jiu VL - 1 ID - Xu2009 ER - TY - JOUR AU - Bao, J. C. AU - Liu, G. AU - Cong, D. L. AU - Zhang, C. X. PY - 2006 DA - 2006// TI - Progress in study of chemical components of Sanqi JO - Zhong Cheng Yao VL - 28 ID - Bao2006 ER - TY - BOOK PY - 2005 DA - 2005// TI - Pharmacopoeia of The People’s Republic of China, vol. 1 PB - People’s Medical Publishing House CY - Beijing ID - ref13 ER - TY - JOUR AU - Zhou, L. AU - Zuo, Z. AU - Chow, M. S. AU - Sing, M. PY - 2005 DA - 2005// TI - Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use JO - J Clin Pharmacol VL - 45 UR - https://doi.org/10.1177/0091270005282630 DO - 10.1177/0091270005282630 ID - Zhou2005 ER - TY - JOUR AU - TO, C. PY - 2007 DA - 2007// TI - Cardiovascular effects of Danshen JO - Int J Cardiol VL - 121 UR - https://doi.org/10.1016/j.ijcard.2007.01.004 DO - 10.1016/j.ijcard.2007.01.004 ID - TO2007 ER - TY - JOUR AU - Li, J. AU - Liu, W. X. AU - Ma, C. M. AU - Chen, L. Y. AU - Liu, J. H. PY - 2009 DA - 2009// TI - Effect of compound Danshen dropping pills on platelet aggregation ratio in patients with aspirin resistance JO - Chin J New Drugs VL - 18 ID - Li2009 ER - TY - JOUR AU - Li, C. Z. AU - Yang, S. C. AU - Zhao, F. D. PY - 1979 DA - 1979// TI - Experimental studies on the mechanism of inhibition upon thrombus formation by salvia miltiorrhiza bunge in vitro JO - Acta Acad Med Primae Shang Hai VL - 6 ID - Li1979 ER - TY - JOUR AU - Yu, W. G. AU - Xu, L. PY - 1994 DA - 1994// TI - Effect of acetylsalvianolic acid a on platelet function JO - Acta Pharm Sin VL - 29 ID - Yu1994 ER - TY - JOUR AU - Li, L. N. PY - 1997 DA - 1997// TI - Water soluble active components of Salvia miltiorrhiza and related plants JO - J Chin Pharm Sci VL - 6 ID - Li1997 ER - TY - JOUR AU - Yang, F. G. AU - Zhang, A. Y. AU - Chen, Z. Y. AU - Lian, Z. X. AU - Liu, G. X. AU - Dong, G. X. PY - 2008 DA - 2008// TI - Effects of salvianolic acid B on cardiovascular endothelial cells and platelet activation in a rabbit model of ischemia–reperfusion JO - J Chin Integr Med VL - 6 UR - https://doi.org/10.3736/jcim20081208 DO - 10.3736/jcim20081208 ID - Yang2008 ER - TY - JOUR AU - Wang, S. B. AU - Tian, S. AU - Yang, F. AU - Yang, H. G. AU - Yang, X. Y. AU - Du, G. H. PY - 2009 DA - 2009// TI - Cardioprotective effect of salvianolic acid a on isoproterenol-induced myocardial infarction in rats JO - Eur J Pharmacol VL - 615 UR - https://doi.org/10.1016/j.ejphar.2009.04.061 DO - 10.1016/j.ejphar.2009.04.061 ID - Wang2009 ER - TY - JOUR AU - Liu, L. AU - Li, J. AU - Zhang, Y. AU - Zhang, S. H. AU - Ye, J. Q. AU - Wen, Z. C. PY - 2014 DA - 2014// TI - Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory JO - Thromb Res VL - 134 UR - https://doi.org/10.1016/j.thromres.2014.07.019 DO - 10.1016/j.thromres.2014.07.019 ID - Liu2014 ER - TY - JOUR AU - Du, G. H. AU - Sun, L. AU - Zhao, R. AU - Du, L. AU - Song, J. K. PY - 2016 DA - 2016// TI - Zhang L, et al polyphenols: potential source of drugs for the treatment of ischaemic heart disease JO - Pharmacol Ther VL - 162 UR - https://doi.org/10.1016/j.pharmthera.2016.04.008 DO - 10.1016/j.pharmthera.2016.04.008 ID - Du2016 ER - TY - JOUR AU - Fan, H. Y. AU - Fu, F. H. AU - Yang, M. Y. AU - Xu, H. AU - Zhang, A. H. AU - Liu, K. PY - 2010 DA - 2010// TI - Antiplatelet and antithrombotic activities of salvianolic acid A JO - Thromb Res VL - 126 UR - https://doi.org/10.1016/j.thromres.2010.04.006 DO - 10.1016/j.thromres.2010.04.006 ID - Fan2010 ER - TY - JOUR AU - Huang, Z. S. AU - Zeng, C. L. AU - Zhu, L. J. AU - Jiang, L. AU - Li, N. AU - Hu, H. PY - 2010 DA - 2010// TI - Salvianolic acid a inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase JO - J Thromb Haemost VL - 8 UR - https://doi.org/10.1111/j.1538-7836.2010.03859.x DO - 10.1111/j.1538-7836.2010.03859.x ID - Huang2010 ER - TY - JOUR AU - Pan, C. AU - Lou, L. AU - Huo, Y. AU - Singh, G. AU - Chen, M. AU - Zhang, D. PY - 2011 DA - 2011// TI - Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways JO - Ther Adv Cardiovasc Dis VL - 5 UR - https://doi.org/10.1177/1753944710396538 DO - 10.1177/1753944710396538 ID - Pan2011 ER - TY - JOUR AU - Wang, S. B. AU - Zhang, W. K. AU - Pang, X. B. AU - Li, L. AU - He, G. R. AU - Yang, X. Y. PY - 2013 DA - 2013// TI - EETs mediate cardioprotection of salvianolic acids through MAPK signaling pathway JO - Acta Pharm Sin B VL - 3 UR - https://doi.org/10.1016/j.apsb.2012.12.006 DO - 10.1016/j.apsb.2012.12.006 ID - Wang2013 ER - TY - JOUR AU - Zhang, W. J. AU - Wojta, J. AU - Binder, B. R. PY - 1997 DA - 1997// TI - Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery JO - Cell Mol Biol VL - 43 ID - Zhang1997 ER - TY - JOUR AU - Ng, T. B. PY - 2006 DA - 2006// TI - Pharmacological activity of sanchi ginseng (Panax notoginseng) JO - J Pharm Pharmacol VL - 58 UR - https://doi.org/10.1211/jpp.58.8.0001 DO - 10.1211/jpp.58.8.0001 ID - Ng2006 ER - TY - JOUR AU - Guo, J. W. AU - Deng, Z. J. AU - Fu, Y. H. AU - Huang, Y. F. AU - Yang, M. AU - Pan, J. Q. PY - 2008 DA - 2008// TI - Effects of Panax Notoginsenosideon potentiating Antioxidationand improving myocardial Morphologyin Ratswith post-myocardial infarction-ventricular remodeling JO - Acta Sci Nat Univ Sunyatseni VL - 42 ID - Guo2008 ER - TY - JOUR AU - Lau, A. J. AU - Toh, D. F. AU - Chua, T. K. AU - Pang, Y. K. AU - Woo, S. O. AU - Koh, H. L. PY - 2009 DA - 2009// TI - Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium JO - J Ethnopharmacol VL - 25 UR - https://doi.org/10.1016/j.jep.2009.07.038 DO - 10.1016/j.jep.2009.07.038 ID - Lau2009 ER - TY - JOUR AU - Wang, M. M. AU - Xue, M. AU - Xu, Y. G. AU - Miao, Y. AU - Kou, N. AU - Yang, L. PY - 2016 DA - 2016// TI - Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro JO - Thromb Res VL - 141 UR - https://doi.org/10.1016/j.thromres.2016.03.022 DO - 10.1016/j.thromres.2016.03.022 ID - Wang2016 ER - TY - JOUR AU - Zhou, L. G. AU - Zheng, G. Z. AU - Gan, F. Y. AU - Wang, S. L. AU - Yang, C. R. AU - Xu, C. PY - 1991 DA - 1991// TI - Separation and identification of main medicinal saponin components from mass cell cultures of Panax notoginseng (Burk) F JO - H Chen Acta Pharm Sin VL - 26 ID - Zhou1991 ER - TY - JOUR AU - Chen, Y. AU - Sorensen, L. K. PY - 2000 DA - 2000// TI - Determination of marker constituents in radix Glycyrrhizae and radix Notoginseng by near infrared spectroscopy JO - Fresenius J Anal Chem VL - 367 UR - https://doi.org/10.1007/s002160000356 DO - 10.1007/s002160000356 ID - Chen2000 ER - TY - JOUR AU - Wang, Y. AU - Bi, K. S. PY - 2003 DA - 2003// TI - Fingerprint construction of Panax notoginseng JO - China J Chin Mater Med VL - 28 ID - Wang2003 ER - TY - JOUR AU - Chen, J. B. AU - Xu, J. W. L. AU - Jiang, H. AU - Huang, C. X. AU - Tang, Q. Z. AU - Li, J. J. PY - 2000 DA - 2000// TI - The effect of notoginsenodise on lipid peroxide and plasminogen activitor of patients with coronary diseases JO - Chin New Drugs J VL - 9 ID - Chen2000 ER - TY - STD TI - Duan L, Xiong XJ, Hu JY, Liu YM, Wang J. Efficacy and safety of oral Panax Notoginseng saponins for unstable angina patients: a meta-analysis and systematic review. Phytomedicine. 2018. https://doi.org/10.1016/j.phymed.2018.04.044. ID - ref37 ER - TY - JOUR AU - Shang, Q. AU - Xu, H. AU - Liu, Z. AU - Chen, K. AU - Liu, J. PY - 2013 DA - 2013// TI - Oral Panax notoginseng preparation for coronary heart disease: a systematic review of randomized controlled trials JO - Evid Based Complement Alternat Med VL - 2013 ID - Shang2013 ER - TY - JOUR AU - Yuan, J. AU - Guo, W. AU - Yang, B. AU - Liu, P. AU - Wang, Q. AU - Yuan, H. PY - 1997 DA - 1997// TI - 116 cases of coronary angina pectoris treated with powder composed of radix ginseng, radix notoginseng and succinum JO - J Tradit Chin Med VL - 17 ID - Yuan1997 ER - TY - JOUR AU - Li, J. AU - Wang, Q. PY - 2001 DA - 2001// TI - Pharmacology advancement in curing coronary heart disease of compound Danshen dripping pills JO - Shanxi J Tradit Chin Med VL - 17 ID - Li2001 ER - TY - JOUR AU - Ding, N. PY - 2002 DA - 2002// TI - Research advancement and clinical application of compound Danshen dripping pills JO - Chin Tradit Herb Drugs VL - 33 ID - Ding2002 ER - TY - JOUR AU - Liu, L. AU - Lu, L. PY - 2005 DA - 2005// TI - Pharmacology and clinical application of Fufang Danshen tablet JO - Heilongjiang Med J VL - 18 ID - Liu2005 ER - TY - JOUR AU - Wu, F. H. AU - Liu, X. M. AU - Jia, R. PY - 2005 DA - 2005// TI - Pharmacodynamic study of Danqi capsule JO - China J Chin Mater Med VL - 30 ID - Wu2005 ER - TY - JOUR AU - Wang, G. AU - Wang, L. AU - Xiong, Z. Y. AU - Mao, B. AU - Li, T. Q. PY - 2006 DA - 2006// TI - Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis JO - Med Sci Monit VL - 12 ID - Wang2006 ER - TY - JOUR AU - Guo, Y. M. AU - Zhang, C. AU - Zha, Q. L. AU - Chen, W. N. AU - Jiang, M. AU - Lv, A. P. PY - 2012 DA - 2012// TI - “Compound Salvia droplet pill” for treatment of coronary heart disease: a systematic review JO - Acta Univ Tradit Med Sinensis Pharmacol Shanghai VL - 26 ID - Guo2012 ER - TY - JOUR AU - Yue, Q. X. AU - Xie, F. B. AU - Song, X. Y. AU - Wu, W. Y. AU - Jiang, B. H. AU - Guan, S. H. PY - 2012 DA - 2012// TI - Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury JO - J Ethnopharmacol VL - 141 UR - https://doi.org/10.1016/j.jep.2011.08.044 DO - 10.1016/j.jep.2011.08.044 ID - Yue2012 ER - TY - JOUR AU - Yao, Y. AU - Wu, W. Y. AU - Liu, A. H. AU - Deng, S. S. AU - Bi, K. S. AU - Liu, X. AU - Guo, D. A. PY - 2008 DA - 2008// TI - Interaction of salvianolic acids and notoginsengnosides in inhibition of ADP-induced platelet aggregation JO - Am J Chin Med VL - 36 UR - https://doi.org/10.1142/S0192415X08005795 DO - 10.1142/S0192415X08005795 ID - Yao2008 ER - TY - JOUR AU - Buoen, C. AU - Bjerrum, O. J. AU - Thomsen, M. S. PY - 2005 DA - 2005// TI - How first-time-in-human studies are being performed: a survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004 JO - J Clin Pharmacol VL - 45 UR - https://doi.org/10.1177/0091270005279943 DO - 10.1177/0091270005279943 ID - Buoen2005 ER - TY - BOOK PY - 2010 DA - 2010// TI - Pharmacopoeia of The People’s Republic of China, vol. 1 PB - People’s Medical Publishing House CY - Beijing ID - ref49 ER - TY - JOUR AU - Behrens, F. AU - Tak, P. P. AU - Østergaard, M. AU - Stoilov, R. AU - Wiland, P. AU - Huizinga, T. W. PY - 2015 DA - 2015// TI - MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204816 DO - 10.1136/annrheumdis-2013-204816 ID - Behrens2015 ER - TY - JOUR AU - Sarashina, A. AU - Sesoko, S. AU - Nakashima, M. AU - Hayashi, N. AU - Taniguchi, A. AU - Horieet Y al. PY - 2010 DA - 2010// TI - Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects JO - Clin Ther VL - 32 UR - https://doi.org/10.1016/j.clinthera.2010.06.004 DO - 10.1016/j.clinthera.2010.06.004 ID - Sarashina2010 ER - TY - JOUR AU - Wang, Y. PY - 2015 DA - 2015// TI - Danqi pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway JO - BMC Complement Altern Med VL - 15 UR - https://doi.org/10.1186/s12906-015-0548-0 DO - 10.1186/s12906-015-0548-0 ID - Wang2015 ER - TY - JOUR AU - Wang, Q. AU - Li, C. AU - Zhang, Q. AU - Wang, Y. AU - Shi, T. AU - Lu, L. PY - 2016 DA - 2016// TI - The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1alpha pathway JO - BMC Complement Altern Med VL - 16 UR - https://doi.org/10.1186/s12906-016-1496-z DO - 10.1186/s12906-016-1496-z ID - Wang2016 ER - TY - JOUR AU - Deng, Y. AU - Zhang, T. AU - Teng, F. AU - Li, D. AU - Xu, F. AU - Cho, K. PY - 2015 DA - 2015// TI - Ginsenoside Rg1 and Rb1, in combination with salvianolic acid B, play different roles in myocardial infarction in rats JO - J Chin Med Assoc VL - 78 UR - https://doi.org/10.1016/j.jcma.2014.10.001 DO - 10.1016/j.jcma.2014.10.001 ID - Deng2015 ER - TY - JOUR AU - Deng, Y. AU - Yang, M. AU - Xu, F. AU - Zhang, Q. AU - Zhao, Q. AU - Yu, H. AU - Li, D. AU - Zhang, G. AU - Lu, A. AU - Cho, K. PY - 2015 DA - 2015// TI - Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia/reperfusion injury in rats JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0135435 DO - 10.1371/journal.pone.0135435 ID - Deng2015 ER -